Literature DB >> 19539854

Serious issues relating to the clinical use of unlicensed botulinum toxin products.

Andy Pickett, Martin Mewies.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19539854     DOI： 10.1016/j.jaad.2008.12.042

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

Review 1.  Botulinum toxin type A products are not interchangeable: a review of the evidence.

Authors:  Mitchell F Brin; Charmaine James; John Maltman
Journal:  Biologics       Date:  2014-10-06

2.  Vasculitis with panniculitis following botulinum toxin A injection for cosmetic use.

Authors:  Nastaran Namazi; Reza M Robati; Sahar Dadkhahfar; Anoush Shafiee; Farahnaz Bidari-Zerehpoush
Journal:  Dermatol Pract Concept       Date:  2016-01-31

Review 3.  Biosecurity Threat Posed by Botulinum Toxin.

Authors:  Orlando Cenciarelli; Paul William Riley; Agoritsa Baka
Journal:  Toxins (Basel)       Date:  2019-11-20       Impact factor: 4.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.